Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

LGBTQ+

Growing pains at WebMD

Health information site increases traffic but sees falling revenues in 2012

- PMLiVE

Novartis gives Vasella honorary role as payout row continues

Named honorary chairman chairman at Swiss pharma firm after stepping down as chairman

- PMLiVE

Second approval in US for Bayer-Onyx’ Stivarga

FDA clears drug to treat patients with gastrointestinal stromal tumours

- PMLiVE

EMA application fees set for slower rise in 2013

European regulator expects rate to increase by 2.6 per cent

- PMLiVE

Takeda-Affymax recall Omontys in US after deaths

Severe allergic reactions reported in kidney disease patients taking anaemia drug

- PMLiVE

Former Glaxo CEO Ernest Mario to chair Chimerix

Pharma veteran has previously also served as CEO of Alza and Reliant

- PMLiVE

Evidence: The unmet need

Only through change can the pharma industry align its products with the unmet needs of payers

- PMLiVE

Service sector salary survey: the results

Following last month's analysis of pharma salaries, we bring you the results from those working on the service side of the healthcare industry

- PMLiVE

Virgo Health opens New York and Singapore offices

Susan Cuozzo will head the US team and Rachel Norager the Singapore team

- PMLiVE

Royalty Pharma mulls bid for Elan

Follows Biogen’s $3.25bn acquisition of Tysabri from Elan

Roche - Basel

Roche’s Herceptin follow-up cleared in US

FDA approval for Kadcyla (formerly T-DM1) in breast cancer

- PMLiVE

Late-stage failure for Merck’s cilengitide in brain cancer

Integrin inhibitor unable to improve overall survival in phase III trials

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links